EXECUTIVE ENGAGEMENTS
OUTREACH
582
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
116
Interactions with Platform & by Email
PARTICIPANTS
23
Unique # Participated
VALIDATIONS
11
Responses Validated*
COMPETITORS
66
Responses Validated*
BRANDS
0
Responses Validated*
* Login for a full stack data experience
DATE
SEP 2020
TABLES
54
PAGES
150
EDITION
17
PRICE
USD $5450
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Biodefense estimated at US$13.5 Billion in the year 2020, is projected to reach a revised size of US$19.5 Billion by 2027, growing at aCAGR of 5.4% over the period 2020-2027. Vaccines, one of the segments analyzed in the report, is projected to record 5.6% CAGR and reach US$12.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biothreat Detection Devices segment is readjusted to a revised 5.1% CAGR for the next 7-year period.
The Biodefense market in the U.S. is estimated at US$4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2027 trailing a CAGR of 5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.
SELECT PLAYERS
Achaogen, Inc.; Alexeter Technologies, LLC; Alnylam Pharmaceuticals, Inc.; Altimmune, Inc.; ANP Technologies, Inc.; Bavarian Nordic A/S; Cleveland BioLabs, Inc.; Elusys Therapeutics, Inc.; Emergent BioSolutions, Inc.; Ichor Medical Systems, Inc.; New Horizons Diagnostic Corporation; PathSensors, Inc.; Research International, Inc.; SIGA Technologies
SEGMENTS
» Product (Vaccines, and Biothreat Detection Devices)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Impact of Covid-19 and a Looming Global Recession |
| Global Competitor Market Shares |
| Biodefense Competitor Market Share Scenario Worldwide (in %): 2018E |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Biodefense by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 |
| World Historic Review for Biodefense by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| World 15-Year Perspective for Biodefense by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 |
| World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Biothreat Detection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 |
| World Historic Review for Biothreat Detection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| World 15-Year Perspective for Biothreat Detection Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| US Biodefense Market Share (in %) by Company: 2018 & 2027 |
| USA Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 |
| USA Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| USA 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| Canada |
| Canada Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 |
| Canada Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| Canada 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| Japan |
| Japan Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 |
| Japan Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| Japan 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| China |
| China Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 |
| China Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| China 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| Europe |
| Market Facts & Figures |
| European Biodefense Market: Competitor Market Share Scenario (in %) for 2018 & 2027 |
| Europe Current & Future Analysis for Biodefense by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 |
| Europe Historic Review for Biodefense by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| Europe 15-Year Perspective for Biodefense by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2018 & 2027 |
| Europe Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 |
| Europe Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| Europe 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| France |
| France Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 |
| France Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| France 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| Germany |
| Germany Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 |
| Germany Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| Germany 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| Italy |
| Italy Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 |
| Italy Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| Italy 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| United Kingdom |
| UK Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 |
| UK Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| UK 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| Rest of Europe |
| Rest of Europe Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 |
| Rest of Europe Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| Rest of Europe 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| Asia-Pacific |
| Asia-Pacific Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 |
| Asia-Pacific Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| Asia-Pacific 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| Rest of World |
| Rest of World Current & Future Analysis for Biodefense by Product - Vaccines and Biothreat Detection Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 |
| Rest of World Historic Review for Biodefense by Product - Vaccines and Biothreat Detection Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 |
| Rest of World 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Vaccines and Biothreat Detection Devices for the Years 2012, 2018 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 66 |
